Pernix Therapeutics Holdings, Inc. (PTXT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10 NORTH PARK PLACE MORRISTOWN, NJ 07960 |
| State of Incorp. | MD |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19,925 | 26,942 | 32,820 | 27,241 | 14,341 | 22,737 | |||
| Cash and cash equivalent | 19,925 | 26,942 | 32,820 | 27,241 | 14,341 | 22,737 | |||
| Receivables | 35,376 | 37,074 | 45,440 | 48,797 | 45,698 | 31,680 | |||
| Inventory, net of allowances, customer advances and progress billings | 5,058 | 5,407 | 5,396 | 8,130 | 8,482 | 7,444 | |||
| Inventory | 5,058 | 5,407 | 5,396 | 8,130 | 8,482 | 7,444 | |||
| Other undisclosed current assets | 6,096 | 7,290 | 10,115 | 8,814 | 13,311 | 15,069 | |||
| Total current assets: | 66,455 | 76,713 | 93,771 | 92,982 | 81,832 | 76,930 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 681 | 670 | 752 | 831 | 921 | 1,013 | |||
| Intangible assets, net (including goodwill), including: | 85,424 | 86,800 | 96,606 | 114,783 | 132,934 | 151,086 | |||
| Goodwill | 12,100 | 12,100 | 12,100 | 30,600 | 30,600 | 30,600 | |||
| Intangible assets, net (excluding goodwill) | 159,848 | 162,600 | 182,212 | 218,566 | 254,868 | 291,172 | |||
| Other undisclosed intangible assets, net (including goodwill) | (86,524) | (87,900) | (97,706) | (134,383) | (152,534) | (170,686) | |||
| Other noncurrent assets | 1,973 | 2,118 | 2,263 | 2,408 | 197 | 235 | |||
| Other undisclosed noncurrent assets | 12,100 | 12,100 | 12,100 | 30,600 | 30,600 | 30,600 | |||
| Total noncurrent assets: | 100,178 | 101,688 | 111,721 | 148,622 | 164,652 | 182,934 | |||
| TOTAL ASSETS: | 166,633 | 178,401 | 205,492 | 241,604 | 246,484 | 259,864 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 10,797 | 8,796 | 80,580 | 22,699 | 23,090 | 20,391 | |||
| Interest and dividends payable | 10,524 | 5,879 | 10,612 | 5,871 | 10,302 | 6,329 | |||
| Employee-related liabilities | 3,661 | 3,129 | 5,748 | ||||||
| Accounts payable | 7,911 | ||||||||
| Accrued liabilities | 3,324 | 6,679 | 56,309 | ||||||
| Other undisclosed accounts payable and accrued liabilities | (6,712) | (6,891) | 16,828 | 12,788 | 14,062 | ||||
| Debt | 3,664 | 14,000 | |||||||
| Other liabilities | 2,648 | ||||||||
| Other undisclosed current liabilities | 75,294 | 78,679 | 6,909 | 70,914 | 71,910 | 67,051 | |||
| Total current liabilities: | 86,091 | 87,475 | 93,801 | 93,613 | 109,000 | 87,442 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 281,165 | 278,829 | 279,976 | 283,747 | 279,482 | 291,894 | |||
| Long-term debt, excluding current maturities | 281,165 | 278,829 | 279,976 | 283,747 | 279,482 | 291,894 | |||
| Liabilities, other than long-term debt | 4,395 | 4,538 | 5,972 | 7,492 | 21,715 | 23,302 | |||
| Estimated litigation liability | 2,000 | 2,000 | 2,000 | 2,000 | 16,797 | 17,410 | |||
| Other liabilities | 822 | 805 | 2,521 | 2,567 | 2,741 | 2,559 | |||
| Business combination, contingent consideration, liability | 1,501 | 1,621 | 1,358 | 2,747 | 1,863 | 2,749 | |||
| Derivative instruments and hedges, liabilities | 72 | 112 | 93 | 178 | 314 | 584 | |||
| Other undisclosed noncurrent liabilities | |||||||||
| Total noncurrent liabilities: | 285,560 | 283,367 | 285,948 | 291,239 | 301,197 | 315,196 | |||
| Total liabilities: | 371,651 | 370,842 | 379,749 | 384,852 | 410,197 | 402,638 | |||
| Equity | |||||||||
| Equity, attributable to parent | (205,018) | (192,441) | (174,257) | (143,248) | (163,713) | (142,774) | |||
| Preferred stock | |||||||||
| Common stock | 121 | 119 | 119 | 115 | 100 | 100 | |||
| Additional paid in capital | 262,492 | 261,558 | 261,158 | 259,794 | 245,713 | 245,054 | |||
| Accumulated other comprehensive income (loss) | (46) | (55) | (73) | ||||||
| Accumulated deficit | (467,631) | (454,118) | (435,534) | (403,111) | (409,471) | (387,855) | |||
| Equity, attributable to noncontrolling interest | |||||||||
| Total equity: | (205,018) | (192,441) | (174,257) | (143,248) | (163,713) | (142,774) | |||
| TOTAL LIABILITIES AND EQUITY: | 166,633 | 178,401 | 205,492 | 241,604 | 246,484 | 259,864 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 21,088 | 28,139 | 41,541 | 40,469 | 34,316 | 29,742 | ||
| Cost of revenue | (6,015) | (8,961) | (15,174) | (11,464) | (10,493) | (10,040) | ||
| Cost of product and service sold | (5,569) | (8,961) | (13,518) | (10,580) | (10,493) | (10,040) | ||
| Gross profit: | 15,073 | 19,178 | 26,367 | 29,005 | 23,823 | 19,702 | ||
| Operating expenses | (19,512) | (28,244) | (51,109) | (27,991) | (37,346) | (39,796) | ||
| Other undisclosed operating income | 886 | |||||||
| Operating income (loss): | (4,439) | (9,066) | (24,742) | 1,014 | (12,637) | (20,094) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (9,065) | (9,479) | (7,430) | 5,373 | (8,939) | (9,313) | ||
| Interest and debt expense | (950) | (920) | 14,650 | (620) | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (13,504) | (19,495) | (33,092) | 21,037 | (21,576) | (30,027) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 950 | 920 | (14,650) | 620 | ||||
| Income (loss) from continuing operations before income taxes: | (13,504) | (18,545) | (32,172) | 6,387 | (21,576) | (29,407) | ||
| Income tax expense | (9) | (39) | (251) | (27) | (40) | (55) | ||
| Income (loss) from continuing operations: | (13,513) | (18,584) | (32,423) | 6,360 | (21,616) | (29,462) | ||
| Income (loss) before gain (loss) on sale of properties: | (13,513) | (18,584) | (32,423) | 6,360 | (21,616) | (29,462) | ||
| Net income (loss): | (13,513) | (18,584) | (32,423) | 6,360 | (21,616) | (29,462) | ||
| Net income attributable to noncontrolling interest | ||||||||
| Net income (loss) available to common stockholders, basic: | (13,513) | (18,584) | (32,423) | 6,360 | (21,616) | (29,462) | ||
| Interest on convertible debt | 599 | |||||||
| Net income (loss) available to common stockholders, diluted: | (13,513) | (18,584) | (32,423) | 6,959 | (21,616) | (29,462) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (13,513) | (18,584) | (32,423) | 6,360 | (21,616) | (29,462) | ||
| Other comprehensive income | 46 | |||||||
| Other undisclosed comprehensive income | ||||||||
| Comprehensive income (loss): | (13,513) | (18,584) | (32,377) | 6,360 | (21,616) | (29,462) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | ||||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 9 | 18 | 6 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (13,513) | (18,584) | (32,377) | 6,369 | (21,598) | (29,456) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.